Physician profile
Samir Sethi
NPI 1881076552
$674.96
in general payments reported to CMS, 2019-2025
12 companies · $152 in 2025
The $152 reported for 2025 was more than what a typical Critical Care Medicine (Anesthesiology) provider received nationally (typical 2025 total: $97.90).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $200 · 2022: $198 · 2023: $125 · 2025: $152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $277.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $276.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $135.18 | 2021 | |
| Merck Sharp & Dohme LLC | $117.14 | 2023-2025 | Bridion |
| Edwards Lifesciences Corporation | $97.05 | 2021-2022 | |
| Chiesi USA, INC. | $71.31 | 2021-2023 | Cleviprex |
| Medtronic, INC. | $55.44 | 2023-2025 | Avalus, Invos |
| Abiomed | $50.38 | 2022-2025 | |
| Pacira Pharmaceuticals Incorporated | $49.87 | 2022-2025 | Exparel |
| Csl Behring | $25.21 | 2022 | |
| Haemonetics Corporation | $23.82 | 2023 | |
| Saranas, INC. | $18.26 | 2022 | |
| La Jolla Pharmaceutical Company | $17.26 | 2025 | Giapreza |
| Karl Storz Endoscopy-America | $14.04 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samir Sethi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.